Long Position on MEDP @ $62.30 on 9/14/2018 (Momentum)

Medpace Holdings, Inc. (MEDP) is a clinical contract research organization.

The firm provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide.

The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in a range of therapeutic areas.

Its clinical development services include medical affairs, clinical trial management, feasibility and start-up study, clinical monitoring, global regulatory affairs, medical writing, biometrics, pharmacovigilance, core laboratory, and quality assurance.

Shares have formed a bullish "flag" and higher share prices are expected for this stock.

Entry Point: $62.30

Stop Loss: $59.10

Trading Range: $30.62 - $63.99

Target Price: $68.53

Updates

1/31/2019 10:43:39 AM

MEDP closed at $64.60

Position closed on 1/31/2019 at price of $64.60 with a 3.69% gain in 139 days.

Back to Portfolio